Japanese health officials have initiated a trial for over-the-counter morning-after pills at selected pharmacies, marking a significant step in accessibility and reproductive healthcare. The trial, conducted by the Japan Pharmaceutical Association, is set to run until early 2024, determining the feasibility of a broader rollout.
About the Pill: The pill, known by its brand name NorLevo, contains levonorgestrel and boasts an efficacy rate of 80%. Recommended for use within 72 hours after unprotected intercourse, the pill aims to provide a timely and accessible option for emergency contraception, according to Japan’s health ministry and Kyodo News.
Customers can acquire the pill at a cost ranging from 7,000 yen ($47) to 9,000 yen ($61) during the trial period. Currently available at 145 pharmacies across the country, Tokyo, Kanagawa, and Osaka are designated to have five to six participating pharmacies, while 44 other prefectures will each have two to three.
How to Obtain Them: To access the morning-after pills, customers must schedule an appointment with the pharmacy beforehand. The trial is open to individuals aged 16 and above, with those between 16 and 17 required to be accompanied by a guardian or parent when making a purchase.
Significance and Implications: The trial carries potential significance for victims of sexual abuse, offering a more accessible option that could potentially reduce the need for abortion and alleviate the physical, mental, and emotional stress associated with such situations.
Impact on Current Practices: The trial also challenges the previous requirement for a doctor’s prescription to obtain emergency contraceptives, potentially streamlining the process for victims of sexual abuse and removing barriers to timely healthcare.
What’s Next: A comprehensive rollout in Japan hinges on various factors, including sales data, pharmacy conditions, and customer feedback. The health ministry is actively seeking additional funding to continue and expand the trial beyond the next fiscal year.
Public Reactions: The news has sparked mixed reactions on Japanese social media platforms. Some express concern over the pricing, while others highlight the importance of ensuring proper distribution and management systems for the pills.
“Isn’t this emergency contraceptive pill sold in stores expensive, being from 7,000 to 9,000 yen??? It used to be 7,500 yen for consultation and prescription, but I didn’t like being asked why I needed it,” one user commented.
Others emphasized the need for a “proper system for purchasing and managing the intake, similar to a medication notebook.”